{"method": [["A total of 108 patients (mean age, 66.7 \u00b1 9.1 years; range, 41e86 years; 49 men) were included in this study.", {"pattern": {"sp_index": 33, "sub": ["total"], "pred": ["were", "included"], "nes": {}, "cds": {"patients": 1, "men": 1, "years": 2}}, "sp": 4, "ne": 0, "cd": 133, "sid": "37", "total": 137, "doc_id": "./anns_v2/Chung et al., (2016) - Apathy and striatal dopamine deficits in non-demented PD patients._annotated_ann.json"}], [" Remy and colleagues performed 11 C-RTI-32 PET, an in vivo marker of both dopamine and noradrenaline transporter binding,  in eight PD patients with depression and twelve PD patients without depression, and found that apathy was inversely correlated with 11 C-RTI-32 PET binding in the ventral striatum [4].", {"pattern": {"sp_index": -1, "sub": ["Remy"], "pred": ["performed", "found"], "nes": {"PET": 2, "Remy": 1}, "cds": {"PET": 1, "]": 1, "patients": 1, "binding": 1}}, "sp": 0, "ne": 16, "cd": 127, "sid": "50", "total": 143, "doc_id": "./anns_v2/Chung et al., (2016) - Apathy and striatal dopamine deficits in non-demented PD patients._annotated_ann.json"}]], "findings": [[" Non-depressed apathetic patients showed higher BDI scores than non-depressed non-apathetic patients (p 1\u20444 0.005).", {"pattern": {"sp_index": 115, "sub": ["patients"], "pred": ["showed"], "nes": {}, "cds": {}}, "sp": 2, "ne": 0, "cd": 0, "sid": "46", "total": 2, "doc_id": "./anns_v2/Chung et al., (2016) - Apathy and striatal dopamine deficits in non-demented PD patients._annotated_ann.json"}], ["This study demonstrated that apathy is not associated with striatal DAT binding defects in PD, in contrast to our initial expec- tations.", {"pattern": {"sp_index": 307, "sub": ["study"], "pred": ["demonstrated"], "nes": {"DAT": 1, "PD": 1}, "cds": {}}, "sp": 1, "ne": 15, "cd": 0, "sid": "48", "total": 16, "doc_id": "./anns_v2/Chung et al., (2016) - Apathy and striatal dopamine deficits in non-demented PD patients._annotated_ann.json"}]], "goal": [["We conducted a survey of the degree of apathy using the self- rated version of the Apathy Evaluation Scale (AES-S) in PD patients who met the following criteria: 1) an initially diagnosed at our hospital by DAT scanning, using a [ 18 F] N-(3-Fluoropropyl)-2 b carbon ethoxy-3 b -(4-iodophenyl) nortropane positron emission tomography ( 18 F -FP-CIT PET) scan, and 2) intact cognitive function, defined as a mini-mental status examination score (MMSE) of 24 or higher.", {"pattern": {"sp_index": 71, "sub": ["We"], "pred": ["conducted"], "nes": {"DAT": 1, "Apathy Evaluation Scale": 1, "MMSE": 1}, "cds": {"PET": 1, "N-": 1}}, "sp": 3, "ne": 41, "cd": 1, "sid": "23", "total": 45, "doc_id": "./anns_v2/Chung et al., (2016) - Apathy and striatal dopamine deficits in non-demented PD patients._annotated_ann.json"}]]}